Entos Finds $53M For Drug Design Platform

San Diego-based Entos, a developer of artificial intelligence and automated synthetic development technology for designing small-molecule therapeutics, has raised $53M in a Series A funding. The funding was led by Coatue, and also included Catalio Capital Management, OrbiMed, Sequoia CApital, Nexus Ventures, and Freeflow. As part of the funding, Aaron Weiner, Managing Director and Head of Healthcare at Coatue, and R. Jacob Vogelstein, Ph.D., Co-Founder and Managing Partner of Catalio, have both joined the company’s board. Entos was founded by Tom Miller (CEO), Fred Manby (CTO), and Naren Gupta (Managing Director of Nexus Venture Partners).